Please login to the form below

Webinar: How to develop an optimal value story for your product

This webinar is part of the ongoing expert insights series run by Valid Insight

Thursday 30th July at 2pm BST / 9am EST

Register now.

Developing a compelling, differentiated, value proposition is crucial for optimal market access. With input from a panel of experts, Raf De Wilde, our Senior Executive Advisor, and Carolyn Steeds, Associate Director, will discuss how to develop a successful payer value strategy while avoiding some of the common pitfalls that experience tells can hinder pricing and market access success.

Expert panelists: 
  • Marcus Dahlman, European Head of Market Access at Hansa Biopharma.
  • Brent Fraser, Vice President of CADTH, Pharmaceutical Reviews.
  • Harry Ward, Former director of Commissioning to Wolverhampton City Primary Care Trust

Register here.

24th July 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Valid Insight are hiring Market Access Writers (Senior Consultant – Payer Value Communication)
We are currently looking for an experienced market access writer for a full-time permanent role as a Senior Consultant - Payer Value Communication.
Valid Insight
Webinar: The value and effective use of RWE in pricing and market access

Valid Insight
Webinar: Maintaining market access through a pandemic, 6 months on
In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.
Valid Insight
Webinar: How to develop an optimal value story for your product
This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight